Literature DB >> 27918526

Mycobacterium tuberculosis EsxH inhibits ESCRT-dependent CD4+ T-cell activation.

Cynthia Portal-Celhay1, JoAnn M Tufariello2,3, Smita Srivastava1, Aleena Zahra1, Thais Klevorn1, Patricia S Grace1, Alka Mehra1, Heidi S Park1, Joel D Ernst1, William R Jacobs2,4, Jennifer A Philips1.   

Abstract

Mycobacterium tuberculosis (Mtb) establishes a persistent infection, despite inducing antigen-specific T-cell responses. Although T cells arrive at the site of infection, they do not provide sterilizing immunity. The molecular basis of how Mtb impairs T-cell function is not clear. Mtb has been reported to block major histocompatibility complex class II (MHC-II) antigen presentation; however, no bacterial effector or host-cell target mediating this effect has been identified. We recently found that Mtb EsxH, which is secreted by the Esx-3 type VII secretion system, directly inhibits the endosomal sorting complex required for transport (ESCRT) machinery. Here, we showed that ESCRT is required for optimal antigen processing; correspondingly, overexpression and loss-of-function studies demonstrated that EsxH inhibited the ability of macrophages and dendritic cells to activate Mtb antigen-specific CD4+ T cells. Compared with the wild-type strain, the esxH-deficient strain induced fivefold more antigen-specific CD4+ T-cell proliferation in the mediastinal lymph nodes of mice. We also found that EsxH undermined the ability of effector CD4+ T cells to recognize infected macrophages and clear Mtb. These results provide a molecular explanation for how Mtb impairs the adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27918526      PMCID: PMC5453184          DOI: 10.1038/nmicrobiol.2016.232

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  50 in total

1.  Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis.

Authors:  Joseph Hinchey; Sunhee Lee; Bo Y Jeon; Randall J Basaraba; Manjunatha M Venkataswamy; Bing Chen; John Chan; Miriam Braunstein; Ian M Orme; Steven C Derrick; Sheldon L Morris; William R Jacobs; Steven A Porcelli
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo.

Authors:  Andrea J Wolf; Beth Linas; Giraldina J Trevejo-Nuñez; Eleanor Kincaid; Toshiki Tamura; Kiyoshi Takatsu; Joel D Ernst
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

Review 3.  The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins.

Authors:  Camilla Raiborg; Harald Stenmark
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

4.  Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.

Authors:  Berta Bosch; Adam C Berger; Sanjay Khandelwal; Erica L Heipertz; Brian Scharf; Laura Santambrogio; Paul A Roche
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

5.  Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells.

Authors:  Günther Baravalle; Hyesuk Park; Megan McSweeney; Mari Ohmura-Hoshino; Yohei Matsuki; Satoshi Ishido; Jeoung-Sook Shin
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

6.  Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages.

Authors:  Maximiliano G Gutierrez; Sharon S Master; Sudha B Singh; Gregory A Taylor; Maria I Colombo; Vojo Deretic
Journal:  Cell       Date:  2004-12-17       Impact factor: 41.582

7.  A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.

Authors:  Kari A Sweeney; Dee N Dao; Michael F Goldberg; Tsungda Hsu; Manjunatha M Venkataswamy; Marcela Henao-Tamayo; Diane Ordway; Rani S Sellers; Paras Jain; Bing Chen; Mei Chen; John Kim; Regy Lukose; John Chan; Ian M Orme; Steven A Porcelli; William R Jacobs
Journal:  Nat Med       Date:  2011-09-04       Impact factor: 53.440

8.  Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2.

Authors:  Niaz Banaiee; Eleanor Z Kincaid; Ulrike Buchwald; William R Jacobs; Joel D Ernst
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

9.  Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells.

Authors:  Chinnaswamy Jagannath; Devin R Lindsey; Subramanian Dhandayuthapani; Yi Xu; Robert L Hunter; N Tony Eissa
Journal:  Nat Med       Date:  2009-03-01       Impact factor: 53.440

10.  Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair trafficking.

Authors:  Alka Mehra; Aleena Zahra; Victor Thompson; Natalie Sirisaengtaksin; Ashley Wells; Maura Porto; Stefan Köster; Kristen Penberthy; Yoshihisha Kubota; Amelie Dricot; Daniel Rogan; Marc Vidal; David E Hill; Andrew J Bean; Jennifer A Philips
Journal:  PLoS Pathog       Date:  2013-10-31       Impact factor: 6.823

View more
  36 in total

1.  Bacterial Protein Reshapes Host Defense toward Antiviral Responses.

Authors:  Hyungjin Eoh; Jae U Jung
Journal:  Mol Cell       Date:  2018-08-16       Impact factor: 17.970

2.  A New ESX-1 Substrate in Mycobacterium marinum That Is Required for Hemolysis but Not Host Cell Lysis.

Authors:  Rachel E Bosserman; Kathleen R Nicholson; Matthew M Champion; Patricia A Champion
Journal:  J Bacteriol       Date:  2019-06-21       Impact factor: 3.490

Review 3.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

4.  Limited Antimycobacterial Efficacy of Epitope Peptide Administration Despite Enhanced Antigen-Specific CD4 T-Cell Activation.

Authors:  Joel D Ernst; Amber Cornelius; Ludovic Desvignes; Jacqueline Tavs; Brian A Norris
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

Review 5.  Esx Systems and the Mycobacterial Cell Envelope: What's the Connection?

Authors:  Rachel E Bosserman; Patricia A Champion
Journal:  J Bacteriol       Date:  2017-08-08       Impact factor: 3.490

Review 6.  Type VII secretion systems: structure, functions and transport models.

Authors:  Angel Rivera-Calzada; Nikolaos Famelis; Oscar Llorca; Sebastian Geibel
Journal:  Nat Rev Microbiol       Date:  2021-05-26       Impact factor: 60.633

Review 7.  Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Authors:  Laurisa Ankley; Sean Thomas; Andrew J Olive
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 8.  Tuberculosis and the art of macrophage manipulation.

Authors:  S Upadhyay; E Mittal; J A Philips
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

Review 9.  Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design.

Authors:  Joel D Ernst
Journal:  Cell Host Microbe       Date:  2018-07-11       Impact factor: 21.023

10.  Mycobacterium tuberculosis is protected from NADPH oxidase and LC3-associated phagocytosis by the LCP protein CpsA.

Authors:  Stefan Köster; Sandeep Upadhyay; Pallavi Chandra; Kadamba Papavinasasundaram; Guozhe Yang; Amir Hassan; Steven J Grigsby; Ekansh Mittal; Heidi S Park; Victoria Jones; Fong-Fu Hsu; Mary Jackson; Christopher M Sassetti; Jennifer A Philips
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.